ArticleBMC cancer2025

Raltitrexed, S-1 and fruquintinib (RSF) in the treatment of refractory metastatic colorectal cancer: study protocol for a multicenter, prospective, single-arm, phase II trial.

Weibing Leng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.